The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
Read Also
- Supreme Court rejects appeal from Omar Khadr, Canadian man once held at Guantanamo
- SIRT investigating ‘serious incident’ in Regina
- Russia is using more Iranian drones to bomb Ukrainian civilians, says US Defense Secretary Lloyd Austin
- A woman was buried alive in a shallow grave. Then her estranged husband forged notes in her name
- Ivan Boesky, stock trader convicted in insider trading scandal, dead at 87, according to reports
- Premier Wab Kinew announces Tuxedo byelection
- Biden White House stays unusually quiet on the death of Iranian president and foreign minister
- Ambulance collides with moose while responding to another moose collision: OPP
- Joe Rogan-backed pharma company sued for peddling health supplements with ‘false’ advertising
- The CFPB's Pyrrhic Supreme Court Victory
Latest CNBC
- WikiLeaks founder Julian Assange can appeal extradition to U.S., UK court rules
- International Criminal Court seeks arrest warrants for Israeli PM Netanyahu, three Hamas leaders
- Britain expands AI safety institute to San Francisco amid scrutiny over regulatory shortcomings
- Iran's President Raisi is dead. What does the leadership void mean for the country and the world?
- UK stocks are outperforming the U.S. and one CIO says they look 'very cheap'
- $9 billion travel tech firm Navan on track to hit profitability this year and 'not far' from IPO, CEO says
- Budget airline Ryanair posts record annual profit as passenger numbers soar above pre-Covid level
- CNBC Daily Open: Dow at record high, Iran’s president dies in helicopter crash
- Musk launches SpaceX’s Starlink internet services in Indonesia, says more investments could come
- This 35-year-old turned a local Indonesian coffee stall into a unicorn startup — today it brings in $100 million a year